Avacta extends Pall Life Sciences’ Optim 1000 distribution agreement to include India

Deal marks Avacta’s entry to the third largest Asia-Pacific biotech market
Optim 1000 (low res)
Optim 1000 (low res)
Spread the Word
Listed Under

Micro-volume Protein Analysis
Protein Characterisation
Distribution Agreement
Drug Development



Sept. 27, 2012 - PRLog -- Avacta Analytical, a leading provider of analytical technologies, has signed a third distribution agreement with Pall Life Sciences – a global leader in filtration, separation and purification – appointing Pall as the Indian distributor for its market-leading Optim 1000 protein drug development tool. The Optim 1000 is an innovative analytical instrument that provides biopharmaceutical developers with information about the viability of candidate drug molecules and formulations much earlier in the drug development process, avoiding costly end stage product failures. The latest collaboration extends the existing North America and South East Asia agreements, granting Pall exclusive marketing and distribution rights to the Optim 1000, to include India.

Alastair Smith, Chief Executive of Avacta Group, commented: “Pall has proved an excellent partner for Avacta, and the success of our existing collaborations in North America and South East Asia was a major factor in the decision to appoint the Company as the sole distributor for the Optim 1000 in India. The Indian biopharma industry is growing rapidly, offering exciting new opportunities, and we look forward to working with Pall in this new territory.”

For more information, visit http://www.avactaanalytical.com/optim-1000

About Avacta Analytical

Avacta Analytical provides services and innovative instrumentation to the biopharmaceutical market. Our focus is to equip customers with a broad range of capabilities, enabling them to develop their therapeutics quicker, cheaper and better.

The groundbreaking Optim 1000 is an innovative analytical instrument designed to probe multiple stability-indicating parameters at high speed using ultra-low sample volumes of proteins and other molecules.

Our services business specialises in supporting characterisation, formulation, comparability and stability studies of therapeutic proteins. We are able to draw upon a wide range of analytical capabilities and aim to give our customers a flexible value-added service.

Avacta Analytical is an ISO 9001 2008 registered company.
Email:***@kdm-communications.com Email Verified
Account Email Address Verified     Account Phone Number Verified     Disclaimer     Report Abuse
kdm Communications PRs
Trending News
Top Daily News
Top Weekly News

Like PRLog?
Click to Share